A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

NCT06023589 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

231

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: Tezepelumab
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]